QUADRAPAX - 21695-970-16 - (Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide)

Alphabetical Index


Drug Information of QUADRAPAX

Product NDC: 21695-970
Proprietary Name: QUADRAPAX
Non Proprietary Name: Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide
Active Ingredient(s): .0194; .1037; 16.2; .0065    mg/5mL; mg/5mL; mg/5mL; mg/5mL & nbsp;   Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide
Administration Route(s): ORAL
Dosage Form(s): ELIXIR
Coding System: National Drug Codes(NDC)

Labeler Information of QUADRAPAX

Product NDC: 21695-970
Labeler Name: Rebel Distributors Corp
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date: 20110506

Package Information of QUADRAPAX

Package NDC: 21695-970-16
Package Description: 473 mL in 1 BOTTLE (21695-970-16)

NDC Information of QUADRAPAX

NDC Code 21695-970-16
Proprietary Name QUADRAPAX
Package Description 473 mL in 1 BOTTLE (21695-970-16)
Product NDC 21695-970
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide
Dosage Form Name ELIXIR
Route Name ORAL
Start Marketing Date 20110506
Marketing Category Name UNAPPROVED DRUG OTHER
Labeler Name Rebel Distributors Corp
Substance Name ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE
Strength Number .0194; .1037; 16.2; .0065
Strength Unit mg/5mL; mg/5mL; mg/5mL; mg/5mL
Pharmaceutical Classes Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA]

Complete Information of QUADRAPAX


General Information